Start Over

NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021

Authors :: Brian R. Gastman
Martin D. Fleming
Anthony J. Olszanski
Jeffrey A. Sosman
Samantha Guild
April K.S. Salama
Susan M. Swetter
Dominick J. DiMaio
Douglas B. Johnson
Richard W. Joseph
Ryan M. Lanning
Rohit Sharma
Joseph J. Skitzki
Anjela Galan
Alison B. Durham
Anita M. Engh
Joel M. Baumgartner
Kenneth F. Grossmann
Genevieve M. Boland
Kari Kendra
Bartosz Chmielowski
Patrick A. Ott
Mark R. Albertini
Giorgos C. Karakousis
Kim Margolin
Nicole R. McMillian
Julie R. Lange
Merrick I. Ross
Christopher A. Barker
Evan Wuthrick
John A. Thompson
Ryan C. Fields
Ashley M. Holder
Source :: Journal of the National Comprehensive Cancer Network. 19:364-376
Publication Year :: 2021
Publisher :: Harborside Press, LLC, 2021.
Abstract: Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis (added in v2.2020), and the following Principles sections: Molecular Testing (added in v2.2019), Systemic Therapy Considerations (added in v2.2020), and Brain Metastases Management (added in v3.2020). The v1.2021 update included additional modifications of these sections and notable revisions to Principles of: Pathology, Surgical Margins for Wide Excision of Primary Melanoma, Sentinel Lymph Node Biopsy, Completion/Therapeutic Lymph Node Dissection, and Radiation Therapy. These NCCN Guidelines Insights discuss the important changes to pathology and surgery recommendations, as well as additions to systemic therapy options for patients with advanced disease.